Literature DB >> 696440

Operative indications in glioblastoma.

H E Diemath.   

Abstract

General aspects of glioblastomas are considered such as preoperative diagnosis, stereotactic punctures for tissue samples, location and tumour size, interference with CSF circulation. The operative risk and different approaches to treatment are discussed, and the results are compared. The described combined treatment of operative, local cytostatic, and irradiation therapy appears promising, with 22% of patients alive, and a maximum survival time of 51/2 years. Attention is drawn to proper information of the patient and his family regarding the disease and possible outcome.

Entities:  

Mesh:

Year:  1978        PMID: 696440     DOI: 10.1007/BF01406638

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  5 in total

1.  [On the local application of cytostatic substances in the brain].

Authors:  F HEPPNER; H E DIEMATH; F L JENKNER
Journal:  Wien Med Wochenschr       Date:  1961-11-04

2.  [On the course of glioblastoma].

Authors:  H E DIEMATH
Journal:  Neurochirurgia (Stuttg)       Date:  1960-07

3.  Postoperative intracavitary chemotherapy of malignant gliomas. A preliminary study using methotrexate.

Authors:  J Garfield; A D Dayan
Journal:  J Neurosurg       Date:  1973-09       Impact factor: 5.115

4.  [Neurological diagnosis and course of glioblastoma].

Authors:  U Vogt
Journal:  Dtsch Med Wochenschr       Date:  1972-05-05       Impact factor: 0.628

5.  Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy.

Authors:  H J Bloom; M J Peckham; A E Richardson; P A Alexander; P M Payne
Journal:  Br J Cancer       Date:  1973-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.